{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-036445","form_type":"8-K","ticker":"NAGE","cik":"0001386570","company_name":"Niagen Bioscience, Inc.","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.864684+00:00","generated_at":"2026-05-17T23:36:06.868544+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Niagen subsidiary ChromaDex signs exclusive NRCL supply deal with W.R. Grace through 2029","bullets":["Exclusive supply of Nicotinamide-beta-Riboside Chloride (NRCL); Grace cannot sell to third parties.","Initial term through April 30, 2029, with automatic 12-month renewals unless 90-day non-renewal notice.","ChromaDex must purchase minimum annual quantities and provide rolling 24-month forecasts with first 12 months binding.","Parties will negotiate a royalty-bearing license to Grace's NRCL manufacturing patents upon termination under specified conditions.","2025 product price set at $[***]/kg; each party may propose up to 5% price adjustment twice per year."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-036445","json":"https://secwatch.observer/filing/0001628280-25-036445.json","markdown":"https://secwatch.observer/filing/0001628280-25-036445.md","text":"https://secwatch.observer/filing/0001628280-25-036445.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025036445/0001628280-25-036445-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1386570/000162828025036445/cdxc-20250725.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:36:06.868544+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}